Peter Lurie, a former FDA associate commissioner and executive director of the Center for Science in the Public Interest, said there is no real evidence that people need these intermediate doses or that whatever it is they add to the GLP-1 actually makes a meaningful difference. Additionally, documents obtained by the Chronicle show that Empower at one point advised physicians on the specific changes they can list on the prescription
For visible and lasting skin brightening effects, an initial course of 8 to 12 sessions is often recommended, followed by monthly maintenance sessions
doi:10.1016/J.COPH.2007.04.005 27
This initial dose allows for tolerance development before escalating to 1.2 mg (weeks 5-8) and ultimately 2.4 mg (week 9 onward)
People with symptoms of deficiency (fatigue, weakness, hair loss)
PubMed laboratory research record [PMID: 25852904] PubMed record related to this compound for laboratory literature review